French drug company Sanofi is trying to toss the entire board at Medivation after the U.S. drugmaker rejected its $9.3 billion takeover bid.
CEO Milton Johnson told investors Tuesday that HCA would continue to focus on facility expansion and smaller, complementary acquisitions rather than “needle-moving” hospital deals.
Missouri insurance officials have issued a preliminary order against the merger between health insurance giants Aetna and Humana, the first state to find a problem with the massive transaction.
Intermountain Healthcare and devicemaker Ethicon, a subsidiary of Johnson & Johnson, are partnering to reduce waste by improving the reprocessing cycle for medical devices. The practice saves money and informs improvements on the design of products.
The state's healthcare industry is expected to grow by 1.8% each year, or 1,300 jobs annually, until 2024. But with the baby boomer population facing retirement, Montana officials fear the demand for healthcare services will exceed the available workforce.
The House Ways and Means Committee unanimously backed legislation that would pare back a Medicare hospital pay increase scheduled for 2018 to pay for allowing under-construction hospital outpatient clinics to receive inpatient rates.
The Arizona Supreme Court says hospitals can go after lawsuit settlements to get additional reimbursement for costs of providing care for some patients covered by the state's Medicaid program.
Value-based payments are, essentially, a capped fee. So to succeed with a value-based payment model, it's about how efficiently and effectively you can deliver care within that capped fee that determines if you can maintain a profitable health system.
The new managers of Verity Health System have their work cut out for them as they seek to revitalize the six safety net hospitals formerly known as the Daughters of Charity Health System.
The Medical University of South Carolina has signed a $36 millioin contract for monitoring equipment for inpatient care with Netherlands-based Royal Philips.
German drug and chemicals company Bayer announced Monday that it has made a $62 billion offer to buy U.S.-based crops and seeds specialist Monsanto.
The rise of high-deductible health insurance is challenging providers across the country to change the way they prepare for and collect payments from people getting hit with large out-of-pocket costs for care.